Yes, even so. Human drug researchers have been doing the same thing for decades. As soon as one pharmaceutical company launches a successful small-molecule drug everyone else jumps to find a minor tweak that will hit the same target (ideally with fewer side effects) while evading the patent. There is already specialized software to help with this process so I'm skeptical that LLM agents would be very helpful for this use case.